Patents by Inventor Antonis Zervos

Antonis Zervos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND COMPOUNDS FOR INHIBITION OF CELL DEATH
    Publication number: 20100311772
    Abstract: The invention is directed to methods and compositions for inhibiting caspase-independent apoptosis. In particular, methods and compositions for inhibiting Omi/HtrA2 activity, as well as method for identifying other inhibitors of Omi/HtrA2. Also disclosed are Omi/HtrA2 specific substrates and methods for identifying other substrates of Omi/HtrA2.
    Type: Application
    Filed: March 31, 2010
    Publication date: December 9, 2010
    Applicant: UNIVERSITY OF CENTRAL FLORIDA
    Inventor: Antonis Zervos
  • Method and compounds for inhibition of cell death
    Patent number: 7713981
    Abstract: The invention is directed to methods and compositions for inhibiting caspase-independent apoptosis. In particular, methods and compositions for inhibiting Omi/HtrA2 activity, as well as method for identifying other inhibitors of Omi/HtrA2. Also disclosed are Omi/HtrA2 specific substrates and methods for identifying other substrates of Omi/HtrA2.
    Type: Grant
    Filed: December 4, 2003
    Date of Patent: May 11, 2010
    Assignee: University of Central Florida
    Inventor: Antonis Zervos
  • Protease inhibitors for treatment of wrinkles
    Publication number: 20050250799
    Abstract: Methods, compositions, and kits are provided for the use of protease inhibitors, such as Ucf-101, to reduce wrinkles or other skin damage.
    Type: Application
    Filed: February 7, 2005
    Publication date: November 10, 2005
    Inventors: Seishiro Fujii, Antonis Zervos, Satoshi Hirakawa, Michael Detmar
  • In vivo construction of DNA libraries
    Patent number: 6841347
    Abstract: The invention provides methods of preparing a plurality of nucleic acid insert molecules. The invention also provides methods of constructing a DNA library in vivo. A kit allowing the interchangeable use of a DNA library in more than one application is also provided. Finally, the invention provides a method for screening subjects for the existence of lesions in a gene encoding a particular protein.
    Type: Grant
    Filed: February 5, 1999
    Date of Patent: January 11, 2005
    Assignee: The General Hospital Corporation
    Inventor: Antonis Zervos
  • Method and compounds for inhibition of cell death
    Publication number: 20040171629
    Abstract: The invention is directed to methods and compositions for inhibiting caspase-independent apoptosis. In particular, methods and compositions for inhibiting Omi/HtrA2 activity, as well as method for identifying other inhibitors of Omi/HtrA2. Also disclosed are Omi/HtrA2 specific substrates and methods for identifying other substrates of Omi/HtrA2.
    Type: Application
    Filed: December 4, 2003
    Publication date: September 2, 2004
    Inventor: Antonis Zervos